Lv1
58 积分 2023-12-22 加入
Anti-TNF-α therapies: the next generation
6小时前
待确认
The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors
22天前
已完结
Drug delivery with carbon nanotubes for in vivo cancer treatment
25天前
已完结
Drug delivery with carbon nanotubes for in vivo cancer treatment
26天前
已完结
ORM-6151: A First-in-Class, Anti-CD33 Antibody-Enabled GSPT1 Degrader for AML
26天前
已完结
Dual-payload ADCs move into first oncology clinical trials
26天前
已完结
Endotoxin removal from protein solutions
2个月前
已完结
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
2个月前
已完结
1115 T-DXd increases immune cell infiltration and enhances activity of immune checkpoint blockade in murine tumor models
4个月前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
4个月前
已完结
皖公网安备34019202002308
